LUC00094I2 - - Google Patents

Info

Publication number: LUC00094I2
Authority: LU; Luxembourg

Application number

LU00094C

Original Assignee

Vifor Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-22

Filing date

2018-12-13

Publication date

2020-01-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41707686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00094(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-12-13 Application filed by Vifor Int Ltd filed Critical Vifor Int Ltd

2018-12-19 Publication of LUC00094I1 publication Critical patent/LUC00094I1/fr

2020-01-23 Publication of LUC00094I2 publication Critical patent/LUC00094I2/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/16—Organic material
- B01J39/18—Macromolecular compounds
- B01J39/20—Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/34—Monomers containing two or more unsaturated aliphatic radicals
- C08F212/36—Divinylbenzene
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/22—Esters containing halogen

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Polymers & Plastics (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Processes Of Treating Macromolecular Substances (AREA)

LU00094C 2008-08-22 2018-12-13 LUC00094I2 (fr)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
US9109708P	2008-08-22	2008-08-22
US9112508P	2008-08-22	2008-08-22
US9111008P	2008-08-22	2008-08-22
US16589409P	2009-04-01	2009-04-01
US16589909P	2009-04-01	2009-04-01
US16590509P	2009-04-02	2009-04-02
PCT/US2009/054706 WO2010022383A2 (fr)	2008-08-22	2009-08-22	Polymères réticulés échangeurs cationiques, compositions et utilisation dans le traitement de l'hyperkaliémie
EP09748557.7A EP2365988B2 (fr)	2008-08-22	2009-08-22	Polymères réticulés échangeurs cationiques, compositions et utilisation dans le traitement de l'hyperkaliémie

Publications (2)

Publication Number	Publication Date
LUC00094I1 LUC00094I1 (fr)	2018-12-19
LUC00094I2 true LUC00094I2 (fr)	2020-01-23

Family

ID=41707686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU00094C LUC00094I2 (fr)	2008-08-22	2018-12-13

Country Status (26)

Country	Link
US (4)	US20110236340A1 (fr)
EP (4)	EP4201408B1 (fr)
JP (7)	JP5756403B2 (fr)
KR (5)	KR102150184B1 (fr)
CN (2)	CN102202670B (fr)
AU (1)	AU2009282721B2 (fr)
BR (1)	BRPI0917853C1 (fr)
CA (1)	CA2735058C (fr)
CY (3)	CY2018002I1 (fr)
DE (1)	DE112009002063T5 (fr)
DK (3)	DK3431094T3 (fr)
ES (4)	ES2545887T5 (fr)
FI (1)	FI3431094T3 (fr)
GB (4)	GB2495427B (fr)
HR (4)	HRP20250774T1 (fr)
HU (4)	HUE025934T2 (fr)
LT (4)	LT3431094T (fr)
LU (1)	LUC00094I2 (fr)
MX (3)	MX2011001893A (fr)
NL (1)	NL300962I2 (fr)
NO (2)	NO2018004I1 (fr)
PL (4)	PL2957286T3 (fr)
PT (3)	PT2957286T (fr)
SI (2)	SI3431094T1 (fr)
SM (2)	SMT201800660T1 (fr)
WO (1)	WO2010022383A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8574716B2 (en) *	2006-01-23	2013-11-05	Hitachi Chemical Co., Ltd.	Ionic polymer devices and methods of fabricating the same
WO2010022380A2 (fr)	2008-08-22	2010-02-25	Relypsa, Inc.	Compositions de polyfluoroacrylate stabilisé par polyol linéaire
EP4201408B1 (fr)	2008-08-22	2025-06-25	Vifor (International) Ltd.	Polymères réticulés échangeurs de cations, compositions et utilisation dans le traitement de l'hyperkaliémie
TR201807469T4 (tr) *	2010-03-20	2018-06-21	Relypsa Inc	Polifloroakrilat partikülleri hazırlamaya yönelik kesintisiz işlem.
CA2827056C (fr)	2011-02-11	2020-07-14	Zs Pharma, Inc	Silicate de zirconium microporeux pour traitement de l'hyperkaliemie
CN108276277A (zh)	2011-06-27	2018-07-13	瑞立普萨公司	丙烯酸酯及衍生物的氟化
CN110028603A (zh) *	2011-06-27	2019-07-19	瑞立普萨公司	用于将聚合酯转化为聚合酸的方法
IN2015DN01369A (fr) *	2012-07-19	2015-07-03	Relypsa Inc
EP2882798B1 (fr) *	2012-08-09	2019-05-08	Patheon Austria GmbH & Co KG	Procédé de séchage de matériaux polymères
ES3059226T3 (en)	2012-10-08	2026-03-19	Vifor Int Ltd	Potassium-binding agents for treating hypertension and hyperkalemia
US10695365B2 (en)	2012-10-22	2020-06-30	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
CN105473151B (zh) *	2013-04-05	2018-09-18	Zs制药公司	用于减少钾和治疗慢性肾病和/或慢性心脏病的微孔硅酸锆和利尿药
KR102674230B1 (ko) *	2014-12-23	2024-06-11	알데릭스, 인코포레이티드	고칼륨혈증의 치료를 위한 조성물 및 방법
JP6624704B2 (ja)	2015-08-31	2019-12-25	日立化成株式会社	尿路上皮疾患の評価のための分子法
US9592253B1 (en)	2015-10-14	2017-03-14	ZS Pharma, Inc.	Extended use zirconium silicate compositions and methods of use thereof
ITUB20159278A1 (it)	2015-12-23	2017-06-23	Rjw Pharma Llc	Procedimento per la sintesi di patiromer
WO2019220450A1 (fr)	2018-05-16	2019-11-21	Solara Active Pharma Sciences Limited	Procédé de préparation de patiromer
MX2021011044A (es) *	2019-03-13	2021-10-13	Astrazeneca Ab	Agentes de union a potasio para su uso en pacientes de hemodialisis.
CN114867710B (zh) *	2019-11-14	2026-03-13	维福(国际)有限公司	2-氟代丙烯酸烷基酯的一步合成
US12522682B2 (en)	2020-03-27	2026-01-13	Vifor (International) Ltd.	Synthesis of methyl 2-fluoroacrylate
WO2023035274A1 (fr) *	2021-09-13	2023-03-16	Waterstone Pharmaceuticals(Wuhan) Co., Ltd.	Médicament polymère pour le traitement de l'hyperkaliémie et son procédé de préparation
US20240139234A1 (en) *	2021-11-17	2024-05-02	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Pharmaceutical polymer for treating hyperkalemia and preparation method thereof
CN114369729B (zh) *	2021-12-28	2023-11-03	江苏容汇通用锂业股份有限公司	一种利用锂矿渣进行浸出液除钾的工艺
CN114394918B (zh) *	2022-01-19	2023-10-20	罗长青	一种2-[[三(羟甲基)甲基]氨基]乙磺酸的制备方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2611730A (en) *	1950-09-02	1952-09-23	Simth Kline & French Lab	Medical preparation for reducing the body level of sodium
US2909462A (en) *	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
US3499960A (en) *	1965-01-25	1970-03-10	Merck & Co Inc	Palatable coated particles of an anion exchange resin
NL137053C (fr) †	1967-01-30
FR2171934B1 (fr) *	1972-02-16	1974-09-13	Rhone Poulenc Sa
US3974272A (en) *	1972-09-01	1976-08-10	Merck & Co., Inc.	Palatable cholestyramine coacervate compositions
US4143130A (en) *	1977-08-29	1979-03-06	Warren-Teed Laboratories, Inc.	Method for treating kidney stones
US4470975A (en) *	1977-10-21	1984-09-11	The Johns Hopkins University	Method and composition for the elimination of water from an animal body
US4380590A (en) *	1978-09-19	1983-04-19	Rohm And Haas Company	Emulsion copolymer cation exchange resins
DE2846187A1 (de) †	1978-10-24	1980-05-08	Bayer Ag	Kunstharze auf basis vernetzter mischpolymerisate aus mono- und polyvinylverbindungen
JPS6090243A (ja) *	1983-10-25	1985-05-21	Nitto Boseki Co Ltd	小球状モノアリルアミン橋かけ重合体の製造方法
US4747881A (en) *	1985-02-05	1988-05-31	Warner-Lambert Company	Ingestible aggregate and delivery system prepared therefrom
US5186937A (en) *	1985-06-07	1993-02-16	A.E.C. Societe De Chimie Organique Et Biologique	Composition for feeding ruminants
IT1190349B (it) *	1986-06-16	1988-02-16	Prodotti Formenti Srl	Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
JPS63218713A (ja) *	1987-02-17	1988-09-12	Daikin Ind Ltd	α−フルオロアクリル酸系重合体ならびに用途
US4837015A (en) *	1987-03-05	1989-06-06	Carolina Medical Products Company, Inc.	Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels
GB8817015D0 (en) *	1988-07-16	1988-08-17	Reckitt & Colmann Prod Ltd	Method of treatment
GB8829088D0 (en) †	1988-12-13	1989-01-25	Smith Kline French Lab	Compounds
US5236701A (en) *	1989-07-19	1993-08-17	Lowchol Scientific Inc.	Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
DE3928990A1 (de)	1989-09-01	1991-03-07	Bayer Ag	Verfahren zur herstellung von (alpha)-fluoroacrylsaeurederivaten
US5112993A (en)	1989-11-14	1992-05-12	E. I. Du Pont De Nemours And Company	Process for the preparation of difluoromaleic anhydride
US5091175A (en) *	1990-05-14	1992-02-25	Erbamont Inc.	Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
DE69016014T2 (de) *	1990-07-04	1995-08-31	Marcin Krotkiewski	Blutdrucksenkendes Präparat.
US5162110A (en) *	1990-12-19	1992-11-10	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Binding theophylline to ion exchange resins
US5281631A (en) *	1991-12-20	1994-01-25	Arch Development Corp.	Phosphonic acid based ion exchange resins
DE69306844T2 (de) †	1992-04-10	1997-07-10	Mitsubishi Chem Corp	Verfahren zur Herstellung von kugelförmigen vernetzten Acrylnitril-Copolymerisaten
DK0656029T3 (da) *	1992-08-20	1999-02-15	Du Pont	Tværbundne polymere ammoniumsalte
US5487888A (en) *	1993-05-20	1996-01-30	Geltex, Inc.	Iron-binding polymers for oral administration
US5607669A (en) *	1994-06-10	1997-03-04	Geltex Pharmaceuticals, Inc.	Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) *	1994-06-10	1997-04-08	Geltex Pharmaceuticals, Inc.	Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) *	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
WO1995014531A1 (fr) *	1993-11-25	1995-06-01	Salternate B.V.	Particules de fixation de cations monovalents, utilisation de ces particules, et procedes d'entrainement et d'elimination des ions sodium et/ou potassium
TW474813B (en) *	1994-06-10	2002-02-01	Geltex Pharma Inc	Alkylated composition for removing bile salts from a patient
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
US5824339A (en) *	1995-09-08	1998-10-20	Takeda Chemical Industries, Ltd	Effervescent composition and its production
US6623759B2 (en) *	1996-06-28	2003-09-23	Astrazeneca Ab	Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US5935599A (en) *	1996-10-28	1999-08-10	The Board Of Trustees Of The University Of Illinois	Polymer-associated liposomes for drug delivery and method of manufacturing the same
KR100440544B1 (ko) *	1998-07-31	2004-07-15	니켄 가가쿠 가부시키가이샤	양이온 교환수지 제제
US6294163B1 (en) *	1998-10-02	2001-09-25	Geltex Pharmaceuticals, Inc.	Polymers containing guanidinium groups as bile acid sequestrants
US6558665B1 (en) *	1999-05-18	2003-05-06	Arch Development Corporation	Encapsulating particles with coatings that conform to size and shape of the particles
US6733780B1 (en) *	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
US20020054903A1 (en) *	1999-10-19	2002-05-09	Joseph Tyler	Direct compression polymer tablet core
DE19951116A1 (de)	1999-10-23	2001-04-26	Bosch Gmbh Robert	Relais, insbesondere für eine Startvorrichtung
DE19962935A1 (de) †	1999-12-24	2001-06-28	Bayer Ag	Verfahren zur Herstellung von vernetzten Ionenaustauschern auf Basis von ungesättigten, aliphatischen Nitrilen
US20030027789A1 (en) *	2000-01-14	2003-02-06	Ippei Yamaoka	Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same
US6994827B2 (en)	2000-06-03	2006-02-07	Symyx Technologies, Inc.	Parallel semicontinuous or continuous reactors
WO2002009734A1 (fr) *	2000-08-01	2002-02-07	Oryza Oil & Fat Chemical Co.,Ltd.	Inhibiteurs d'absorption de sucre et leur procede de production
US6908609B2 (en) *	2000-11-20	2005-06-21	Dow Global Technologies Inc.	In vivo use of water absorbent polymers
US7033639B2 (en) *	2001-05-16	2006-04-25	Rohm And Haas Company	Polyaniline coating composition
US6881484B2 (en) *	2001-05-30	2005-04-19	Mitsubishi Kagaku Iatron, Inc.	Core-shell particle including signal-generating substance enclosed therein and process for producing the same
CA2516457C (fr) *	2003-02-25	2011-12-06	Finnfeeds Finland Oy	Systeme et procede d'un lit mobile simule
US7381428B2 (en)	2003-08-26	2008-06-03	Shire International Licensing B.V.	Stabilized lanthanum carbonate compositions
US7854924B2 (en) *	2004-03-30	2010-12-21	Relypsa, Inc.	Methods and compositions for treatment of ion imbalances
US8192758B2 (en) *	2004-03-30	2012-06-05	Relypsa, Inc.	Ion binding compositions
US8282960B2 (en) *	2004-03-30	2012-10-09	Relypsa, Inc.	Ion binding compositions
US7556799B2 (en) †	2004-03-30	2009-07-07	Relypsa, Inc.	Ion binding polymers and uses thereof
KR101153035B1 (ko)	2004-03-30	2012-06-11	리립사, 인크.	이온 결합 조성물
US7429394B2 (en) *	2004-03-30	2008-09-30	Relypsa, Inc.	Ion binding compositions
CN101321519A (zh) *	2005-09-30	2008-12-10	伊立普萨公司	制备含有交联壳的核-壳型复合物的方法及其得到的核-壳型复合物
WO2007038801A2 (fr) †	2005-09-30	2007-04-05	Ilypsa, Inc.	Compositions de liaison aux cations monovalents comprenant des particules coeur-ecorce avec des ecorces polyvinyliques reticulees et procedes pour les utiliser
JP2009510126A (ja) *	2005-09-30	2009-03-12	レリプサ，インコーポレイテッド	哺乳類の胃腸管からカリウムイオンを選択的に除去するための方法および組成物
JP2010538016A (ja) *	2007-08-29	2010-12-09	ソーベントセラピューティクスインコーポレイテッド	異なる対イオン含有量を有する吸収性ポリマー組成物、ならびにその調製および使用の方法
US20100111892A1 (en) *	2008-08-22	2010-05-06	Relypsa, Inc.	Crosslinked polyfluoroacrylic acid and processes for the preparation thereof
EP4201408B1 (fr) †	2008-08-22	2025-06-25	Vifor (International) Ltd.	Polymères réticulés échangeurs de cations, compositions et utilisation dans le traitement de l'hyperkaliémie
WO2010022380A2 (fr) *	2008-08-22	2010-02-25	Relypsa, Inc.	Compositions de polyfluoroacrylate stabilisé par polyol linéaire
WO2010022381A1 (fr) *	2008-08-22	2010-02-25	Relypsa, Inc.	Traitement d'une hyperkaliémie par des polymères d'échange de cation réticulés ayant des propriétés physiques améliorées

2009
- 2009-08-22 EP EP22211737.6A patent/EP4201408B1/fr active Active
- 2009-08-22 LT LTEP18188764.7T patent/LT3431094T/lt unknown
- 2009-08-22 ES ES09748557T patent/ES2545887T5/es active Active
- 2009-08-22 CN CN200980137593.3A patent/CN102202670B/zh active Active
- 2009-08-22 ES ES18188764T patent/ES2939021T3/es active Active
- 2009-08-22 HU HUE09748557A patent/HUE025934T2/en unknown
- 2009-08-22 DE DE112009002063T patent/DE112009002063T5/de not_active Ceased
- 2009-08-22 PT PT15171701T patent/PT2957286T/pt unknown
- 2009-08-22 EP EP09748557.7A patent/EP2365988B2/fr active Active
- 2009-08-22 AU AU2009282721A patent/AU2009282721B2/en active Active
- 2009-08-22 EP EP18188764.7A patent/EP3431094B1/fr active Active
- 2009-08-22 PT PT97485577T patent/PT2365988E/pt unknown
- 2009-08-22 MX MX2011001893A patent/MX2011001893A/es active IP Right Grant
- 2009-08-22 PL PL15171701T patent/PL2957286T3/pl unknown
- 2009-08-22 HR HRP20250774TT patent/HRP20250774T1/hr unknown
- 2009-08-22 SI SI200932178T patent/SI3431094T1/sl unknown
- 2009-08-22 KR KR1020187035573A patent/KR102150184B1/ko active Active
- 2009-08-22 ES ES15171701T patent/ES2699494T3/es active Active
- 2009-08-22 JP JP2011524060A patent/JP5756403B2/ja active Active
- 2009-08-22 SM SM20180660T patent/SMT201800660T1/it unknown
- 2009-08-22 SI SI200931889T patent/SI2957286T1/sl unknown
- 2009-08-22 US US13/060,207 patent/US20110236340A1/en not_active Abandoned
- 2009-08-22 WO PCT/US2009/054706 patent/WO2010022383A2/fr not_active Ceased
- 2009-08-22 GB GB1222750.0A patent/GB2495427B/en active Active
- 2009-08-22 CN CN201410106433.5A patent/CN103919792B/zh active Active
- 2009-08-22 DK DK18188764.7T patent/DK3431094T3/da active
- 2009-08-22 HR HRP20150955TT patent/HRP20150955T1/hr unknown
- 2009-08-22 KR KR1020187002772A patent/KR101928973B1/ko active Active
- 2009-08-22 HU HUE18188764A patent/HUE061320T2/hu unknown
- 2009-08-22 PT PT181887647T patent/PT3431094T/pt unknown
- 2009-08-22 GB GB1104561.4A patent/GB2475657B/en active Active
- 2009-08-22 LT LTEP15171701.4T patent/LT2957286T/lt unknown
- 2009-08-22 EP EP15171701.4A patent/EP2957286B1/fr active Active
- 2009-08-22 FI FIEP18188764.7T patent/FI3431094T3/fi active
- 2009-08-22 KR KR1020207006869A patent/KR102178208B1/ko active Active
- 2009-08-22 KR KR1020207032030A patent/KR102300471B1/ko not_active Expired - Fee Related
- 2009-08-22 PL PL22211737.6T patent/PL4201408T3/pl unknown
- 2009-08-22 PL PL18188764.7T patent/PL3431094T3/pl unknown
- 2009-08-22 MX MX2019004453A patent/MX389664B/es unknown
- 2009-08-22 HU HUE22211737A patent/HUE071829T2/hu unknown
- 2009-08-22 KR KR1020117006635A patent/KR101825113B1/ko not_active Expired - Fee Related
- 2009-08-22 ES ES22211737T patent/ES3034535T3/es active Active
- 2009-08-22 PL PL09748557T patent/PL2365988T5/pl unknown
- 2009-08-22 DK DK09748557.7T patent/DK2365988T4/da active
- 2009-08-22 HR HRP20230091TT patent/HRP20230091T1/hr unknown
- 2009-08-22 DK DK15171701.4T patent/DK2957286T3/en active
- 2009-08-22 BR BRPI0917853A patent/BRPI0917853C1/pt active IP Right Grant
- 2009-08-22 MX MX2015000657A patent/MX364398B/es unknown
- 2009-08-22 CA CA2735058A patent/CA2735058C/fr active Active
2012
- 2012-12-17 GB GB1222749.2A patent/GB2495426A/en not_active Withdrawn
- 2012-12-17 GB GB1222752.6A patent/GB2495428A/en not_active Withdrawn
2014
- 2014-05-12 JP JP2014098678A patent/JP2014144978A/ja not_active Withdrawn
- 2014-05-12 JP JP2014098677A patent/JP5883471B2/ja active Active
2015
- 2015-09-02 SM SM201500207T patent/SMT201500207T1/xx unknown
2016
- 2016-05-12 JP JP2016095867A patent/JP6232468B2/ja active Active
2017
- 2017-02-27 US US15/443,664 patent/US20170165292A1/en not_active Abandoned
- 2017-09-21 JP JP2017181132A patent/JP6633583B2/ja active Active
2018
- 2018-01-15 LT LTPA2018004C patent/LTPA2018004I1/lt unknown
- 2018-01-15 CY CY2018002C patent/CY2018002I1/el unknown
- 2018-01-17 NO NO2018004C patent/NO2018004I1/no unknown
- 2018-11-22 HR HRP20181961TT patent/HRP20181961T1/hr unknown
- 2018-11-29 CY CY20181101268T patent/CY1120930T1/el unknown
- 2018-12-13 LU LU00094C patent/LUC00094I2/fr unknown
- 2018-12-13 LT LTPA2018016 patent/LTC2957286I2/lt unknown
- 2018-12-14 NL NL300962C patent/NL300962I2/nl unknown
- 2018-12-14 NO NO2018041C patent/NO2018041I1/no unknown
- 2018-12-21 JP JP2018238997A patent/JP6890116B2/ja active Active
2019
- 2019-01-09 CY CY2019002C patent/CY2019002I1/el unknown
- 2019-01-15 HU HUS1900003C patent/HUS1900003I1/hu unknown
- 2019-11-01 US US16/672,005 patent/US20200289550A1/en not_active Abandoned
2020
- 2020-07-10 JP JP2020119093A patent/JP2020172537A/ja not_active Withdrawn
2021
- 2021-05-18 US US17/323,627 patent/US20220000906A1/en not_active Abandoned

Also Published As

Publication number	Publication date
GB2495428A (en)	2013-04-10
CY1120930T1 (el)	2020-05-29
LUC00094I1 (fr)	2018-12-19
PT3431094T (pt)	2023-03-03
HUE025934T2 (en)	2016-05-30
EP4201408B1 (fr)	2025-06-25
BRPI0917853A2 (pt)	2015-11-24
DK3431094T3 (da)	2023-02-20
JP2014144978A (ja)	2014-08-14
US20220000906A1 (en)	2022-01-06
PL2365988T3 (pl)	2015-12-31
GB201222750D0 (en)	2013-01-30
ES2939021T3 (es)	2023-04-18
EP2365988B1 (fr)	2015-07-22
EP2365988B2 (fr)	2019-07-03
HRP20181961T1 (hr)	2019-02-08
JP6890116B2 (ja)	2021-06-18
GB201222752D0 (en)	2013-01-30
KR20200029614A (ko)	2020-03-18
KR20180014845A (ko)	2018-02-09
GB2495426A (en)	2013-04-10
CY2018002I1 (el)	2019-07-10
NO2018004I1 (no)	2018-01-17
GB2475657A (en)	2011-05-25
EP2957286A1 (fr)	2015-12-23
PL2957286T3 (pl)	2019-03-29
PL2365988T5 (pl)	2019-11-29
JP2016145256A (ja)	2016-08-12
GB2495427B (en)	2013-08-07
SMT201500207T1 (it)	2015-10-30
KR101825113B1 (ko)	2018-02-02
DK2957286T3 (en)	2018-12-17
PT2365988E (pt)	2015-10-22
FI3431094T3 (fi)	2023-03-20
HRP20250774T1 (hr)	2025-08-29
SMT201800660T1 (it)	2019-01-11
GB2475657B (en)	2013-05-29
JP5756403B2 (ja)	2015-07-29
WO2010022383A3 (fr)	2010-09-23
JP2020172537A (ja)	2020-10-22
MX2011001893A (es)	2011-09-27
CY2019002I2 (el)	2020-05-29
GB201104561D0 (en)	2011-05-04
US20200289550A1 (en)	2020-09-17
MX389664B (es)	2025-03-20
KR102150184B1 (ko)	2020-08-31
CA2735058C (fr)	2021-01-26
HUE071829T2 (hu)	2025-09-28
HRP20150955T1 (hr)	2015-10-09
KR20200128600A (ko)	2020-11-13
LTPA2018004I1 (lt)	2018-02-12
EP4201408A1 (fr)	2023-06-28
US20110236340A1 (en)	2011-09-29
ES3034535T3 (en)	2025-08-19
SI2957286T1 (sl)	2018-12-31
AU2009282721B2 (en)	2015-10-29
EP4201408C0 (fr)	2025-06-25
JP6232468B2 (ja)	2017-11-15
MX364398B (es)	2019-04-24
JP6633583B2 (ja)	2020-01-22
NO2018041I1 (fr)	2018-12-14
LT2957286T (lt)	2018-12-10
KR20180133561A (ko)	2018-12-14
EP3431094B1 (fr)	2022-12-07
BRPI0917853C1 (pt)	2021-05-25
BRPI0917853B1 (pt)	2020-04-07
NL300962I1 (nl)	2018-12-28
JP5883471B2 (ja)	2016-03-15
GB2495427A (en)	2013-04-10
HUS1900003I1 (hu)	2019-02-28
US20170165292A1 (en)	2017-06-15
SI3431094T1 (sl)	2023-04-28
EP3431094A1 (fr)	2019-01-23
EP2365988A2 (fr)	2011-09-21
WO2010022383A2 (fr)	2010-02-25
CA2735058A1 (fr)	2010-02-25
LT3431094T (lt)	2023-02-27
CN103919792B (zh)	2018-03-09
HUE061320T2 (hu)	2023-06-28
DK2365988T4 (da)	2019-10-07
PL4201408T3 (pl)	2025-09-22
KR102300471B1 (ko)	2021-09-30
PT2957286T (pt)	2018-11-30
DK2365988T3 (en)	2015-10-26
JP2019065030A (ja)	2019-04-25
JP2012500806A (ja)	2012-01-12
KR101928973B1 (ko)	2018-12-13
NL300962I2 (nl)	2020-06-02
ES2545887T5 (es)	2020-02-17
PL3431094T3 (pl)	2023-04-24
ES2699494T3 (es)	2019-02-11
LTPA2018016I1 (lt)	2019-01-10
KR102178208B1 (ko)	2020-11-12
JP2014144977A (ja)	2014-08-14
DE112009002063T5 (de)	2012-01-12
HK1184675A1 (en)	2014-01-30
JP2017218454A (ja)	2017-12-14
GB201222749D0 (en)	2013-01-30
CY2019002I1 (el)	2020-05-29
AU2009282721A1 (en)	2010-02-25
HRP20230091T1 (hr)	2023-03-17
KR20110063647A (ko)	2011-06-13
CN103919792A (zh)	2014-07-16
BRPI0917853B8 (pt)	2020-04-22
LTC2957286I2 (lt)	2019-11-25
CN102202670B (zh)	2014-04-30
ES2545887T3 (es)	2015-09-16
EP2957286B1 (fr)	2018-11-21
CN102202670A (zh)	2011-09-28

Publication	Publication Date	Title
BR112016019572A2 (fr)	2017-08-15
BRPI0909040A2 (fr)	2017-09-19
BRPI0917573A2 (fr)	2017-07-11
BRPI0908549B8 (fr)	2021-06-08
BRPI0918697A2 (fr)	2017-08-29
BRPI0917525A2 (fr)	2017-07-04
BRPI0920750A2 (fr)	2016-02-02
BRPI0917618A8 (fr)	2019-09-10
BRPI0922455A2 (fr)	2021-12-28
BRPI0923734A2 (fr)	2017-07-11
BRPI0912727A2 (fr)	2017-08-29
BRPI0922669A2 (fr)	2017-07-11
BRPI0908285A2 (fr)	2017-08-29
BRPI0914750A2 (fr)	2017-08-15
BRPI0910485A2 (fr)	2017-08-29
BRPI0919811A2 (fr)	2017-08-29
BRPI0915616A2 (fr)	2016-02-02
BRPI0912462A2 (fr)	2016-02-02
BRPI0908120A2 (fr)	2017-08-22
BRPI0904541A8 (fr)	2010-09-21
BRPI0920914A2 (fr)	2017-07-11
BRPI0916284A2 (fr)	2017-08-08
BRPI0913605A2 (fr)	2017-07-25
BRPI0911617A2 (fr)	2017-07-25
CH2347250H2 (fr)	2019-09-13